These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23997989)

  • 21. Novel oncogenic mutations of CBL in human acute myeloid leukemia that activate growth and survival pathways depend on increased metabolism.
    Fernandes MS; Reddy MM; Croteau NJ; Walz C; Weisbach H; Podar K; Band H; Carroll M; Reiter A; Larson RA; Salgia R; Griffin JD; Sattler M
    J Biol Chem; 2010 Oct; 285(42):32596-605. PubMed ID: 20622007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. E3 ligase-defective Cbl mutants lead to a generalized mastocytosis and myeloproliferative disease.
    Bandi SR; Brandts C; Rensinghoff M; Grundler R; Tickenbrock L; Köhler G; Duyster J; Berdel WE; Müller-Tidow C; Serve H; Sargin B;
    Blood; 2009 Nov; 114(19):4197-208. PubMed ID: 19734451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of c-Cbl as a new ligase for insulin-like growth factor-I receptor with distinct roles from Mdm2 in receptor ubiquitination and endocytosis.
    Sehat B; Andersson S; Girnita L; Larsson O
    Cancer Res; 2008 Jul; 68(14):5669-77. PubMed ID: 18632619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Ubiquitin Ligases c-Cbl and Cbl-b Negatively Regulate Platelet-derived Growth Factor (PDGF) BB-induced Chemotaxis by Affecting PDGF Receptor β (PDGFRβ) Internalization and Signaling.
    Rorsman C; Tsioumpekou M; Heldin CH; Lennartsson J
    J Biol Chem; 2016 May; 291(22):11608-18. PubMed ID: 27048651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of CBL family ubiquitin ligases in cancer progression and therapeutic strategies.
    Ren J; Lv L; Tao X; Zhai X; Chen X; Yu H; Zhao X; Kong X; Yu Z; Dong D; Liu J
    Front Pharmacol; 2024; 15():1432545. PubMed ID: 39130630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of ubiquitin protein ligase activity in c-Cbl by phosphorylation-induced conformational change and constitutive activation by tyrosine to glutamate point mutations.
    Kassenbrock CK; Anderson SM
    J Biol Chem; 2004 Jul; 279(27):28017-27. PubMed ID: 15117950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SLAP2 Adaptor Binding Disrupts c-CBL Autoinhibition to Activate Ubiquitin Ligase Function.
    Wybenga-Groot LE; Tench AJ; Simpson CD; Germain JS; Raught B; Moran MF; McGlade CJ
    J Mol Biol; 2021 Apr; 433(8):166880. PubMed ID: 33617900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A mouse with a loss-of-function mutation in the c-Cbl TKB domain shows perturbed thymocyte signaling without enhancing the activity of the ZAP-70 tyrosine kinase.
    Thien CB; Scaife RM; Papadimitriou JM; Murphy MA; Bowtell DD; Langdon WY
    J Exp Med; 2003 Feb; 197(4):503-13. PubMed ID: 12591907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Negative regulation of Lck by Cbl ubiquitin ligase.
    Rao N; Miyake S; Reddi AL; Douillard P; Ghosh AK; Dodge IL; Zhou P; Fernandes ND; Band H
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3794-9. PubMed ID: 11904433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-throughput fluorescence polarization assay to identify inhibitors of Cbl(TKB)-protein tyrosine kinase interactions.
    Kumar EA; Charvet CD; Lokesh GL; Natarajan A
    Anal Biochem; 2011 Apr; 411(2):254-60. PubMed ID: 21129358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The N terminus of Cbl-c regulates ubiquitin ligase activity by modulating affinity for the ubiquitin-conjugating enzyme.
    Ryan PE; Sivadasan-Nair N; Nau MM; Nicholas S; Lipkowitz S
    J Biol Chem; 2010 Jul; 285(31):23687-98. PubMed ID: 20525694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cbl-b negatively regulates B cell antigen receptor signaling in mature B cells through ubiquitination of the tyrosine kinase Syk.
    Sohn HW; Gu H; Pierce SK
    J Exp Med; 2003 Jun; 197(11):1511-24. PubMed ID: 12771181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. c-Cbl and Cbl-b ubiquitin ligases: substrate diversity and the negative regulation of signalling responses.
    Thien CB; Langdon WY
    Biochem J; 2005 Oct; 391(Pt 2):153-66. PubMed ID: 16212556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel CBL-Bflox/flox mouse model allows tissue-selective fully conditional CBL/CBL-B double-knockout: CD4-Cre mediated CBL/CBL-B deletion occurs in both T-cells and hematopoietic stem cells.
    Goetz B; An W; Mohapatra B; Zutshi N; Iseka F; Storck MD; Meza J; Sheinin Y; Band V; Band H
    Oncotarget; 2016 Aug; 7(32):51107-51123. PubMed ID: 27276677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A conserved DpYR motif in the juxtamembrane domain of the Met receptor family forms an atypical c-Cbl/Cbl-b tyrosine kinase binding domain binding site required for suppression of oncogenic activation.
    Peschard P; Ishiyama N; Lin T; Lipkowitz S; Park M
    J Biol Chem; 2004 Jul; 279(28):29565-71. PubMed ID: 15123609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Negative regulation of PTK signalling by Cbl proteins.
    Thien CB; Langdon WY
    Growth Factors; 2005 Jun; 23(2):161-7. PubMed ID: 16019438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Casitas B lineage lymphoma (Cbl) mutant G306E enhances osteogenic differentiation in human mesenchymal stromal cells in part by decreased Cbl-mediated platelet-derived growth factor receptor alpha and fibroblast growth factor receptor 2 ubiquitination.
    Sévère N; Miraoui H; Marie PJ
    J Biol Chem; 2011 Jul; 286(27):24443-50. PubMed ID: 21596750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1.
    Levkowitz G; Waterman H; Ettenberg SA; Katz M; Tsygankov AY; Alroy I; Lavi S; Iwai K; Reiss Y; Ciechanover A; Lipkowitz S; Yarden Y
    Mol Cell; 1999 Dec; 4(6):1029-40. PubMed ID: 10635327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nexus of signaling and endocytosis in oncogenesis driven by non-small cell lung cancer-associated epidermal growth factor receptor mutants.
    Chung BM; Tom E; Zutshi N; Bielecki TA; Band V; Band H
    World J Clin Oncol; 2014 Dec; 5(5):806-23. PubMed ID: 25493220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Negative regulation of Lyn protein-tyrosine kinase by c-Cbl ubiquitin-protein ligase in Fc epsilon RI-mediated mast cell activation.
    Kyo S; Sada K; Qu X; Maeno K; Miah SM; Kawauchi-Kamata K; Yamamura H
    Genes Cells; 2003 Oct; 8(10):825-36. PubMed ID: 14531861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.